Concepedia

Stephanie Vrede

SV

Statistics

Publications

5

Citations

135

H-Index

5

Active since

2021

Affiliations

Radboud University Medical Center(Current)

Radboud University Nijmegen

Masaryk University

Centro de Investigación Biomédica en Red de Cáncer

Canisius-Wilhelmina Ziekenhuis

Stephanie Vrede is an author at Radboud University Medical Center specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2021–2024

5

Publications

5

Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer

Stephanie Vrede, Willem Jan van Weelden, Nicole C.M. Visser et al. · Gynecologic Oncology · 2021 · 37 citations · Full text

, , +14

Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma

Antonella Ravaggi, Davide Capoferri, Laura Ardighieri et al. · Cancers · 2022 · 31 citations · Full text

, , +17

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer

Stephanie Vrede, Jenneke C. Kasius, Johan Bulten et al. · JAMA Network Open · 2022 · 29 citations · Full text

, , +17

Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer

Stephanie Vrede, Willem Jan van Weelden, Johan Bulten et al. · Gynecologic Oncology · 2024 · 27 citations · Full text

, , +16

External validation study of endometrial cancer preoperative risk stratification model (ENDORISK)

Petra Vinklerová, Petra Ovesná, Jitka Hausnerová et al. · Frontiers in Oncology · 2022 · 11 citations · Full text

, , +17

1–5 of 5